0 Σχόλια
0 Μοιράστηκε
452 Views
0 Προεπισκόπηση
Αναζήτηση
Ανακάλυψε νέους ανθρώπους, δημιούργησε νέες συνδέσεις και κάνε καινούργιους φίλους
-
Ροή Δημοσιεύσεων
- ΑΝΑΚΆΛΥΨΕ
-
Σελίδες
-
Ομάδες
-
Events
-
Blogs
-
Marketplace
-
Forum
-
Παρακαλούμε συνδέσου στην Κοινότητά μας για να δηλώσεις τι σου αρέσει, να σχολιάσεις και να μοιραστείς με τους φίλους σου!
-
Antibody Drug Conjugates Market Expansion with New Cancer TherapiesNorth America currently holds a significant share in the antibody drug conjugates market due to strong research infrastructure and high healthcare spending. The presence of major pharmaceutical companies also supports regional growth. The Antibody Drug Conjugates (ADC) market is projected to grow significantly, reaching US$38,077.45 million by 2031 from US$8,105.65 million in 2023, registering...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
-
Are Neoantigen Cancer Vaccines the Next Breakthrough in Personalized Oncology?Executive Summary Neoantigen Cancer Vaccine Therapy Market Market Size and Share Forecast CAGR Value The global neoantigen cancer vaccine therapy market size was valued at USD 986 Million in 2025 and is expected to reach USD 6547.71 Million by 2033, at a CAGR of 26.70% during the forecast period The comprehensive market information and data of...0 Σχόλια 0 Μοιράστηκε 562 Views 0 Προεπισκόπηση
-
Are Personalized Cancer Vaccines the Future of Oncology Treatment?Latest Insights on Executive Summary Personalized Cancer Vaccines Market Share and Size CAGR Value Data Bridge Market Research analyses that the global personalized cancer vaccines market which was USD 2,34,790.00 million in 2022, is expected to reach USD 3,71,404.60 million by 2030, and is expected to undergo a CAGR of 5.9% during the forecast period of 2023 to 2030. The market...0 Σχόλια 0 Μοιράστηκε 69 Views 0 Προεπισκόπηση
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 Σχόλια 0 Μοιράστηκε 81 Views 0 Προεπισκόπηση
-
Can Immune-Modulating Biologic Drugs Redefine Cancer Treatment Worldwide?Executive Summary Immune-Modulating Oncology Biologic Drugs Market Market Size and Share Analysis Report CAGR Value The global immune-modulating oncology biologic drugs market size was valued at USD 10.10 billion in 2025 and is expected to reach USD 28.54 billion by 2033, at a CAGR of13.87% during the forecast period This Immune-Modulating...0 Σχόλια 0 Μοιράστηκε 576 Views 0 Προεπισκόπηση
-
Can RNA Therapeutics Unlock a New Era in Disease Treatment?Key Drivers Impacting Executive Summary RNA Therapeutics Market Size and Share CAGR Value During the forecast period of 2025 to 2032 the market is likely to grow at a CAGR of 13.20%, primarily driven by the advancements in mRNA technology, increasing prevalence of chronic diseases, and rising investments in personalized medicine This global RNA Therapeutics Market...0 Σχόλια 0 Μοιράστηκε 241 Views 0 Προεπισκόπηση
-
Global Neurofibromatosis Drugs Market Outlook 2034: Trends, Forecasts, and Growth OpportunitiesDrugs for Neurofibromatosis are designed to treat tumors that develop along nerves in the body. They may include targeted therapies that control abnormal cell growth. These treatments help improve patient quality of life. Neurofibromatosis Drugs Market Size and Growth Outlook (2026–2034) The global Neurofibromatosis Drugs Market size is projected to reach US$ 12.34 billion...0 Σχόλια 0 Μοιράστηκε 738 Views 0 Προεπισκόπηση
-
How Are Synthetic Lethality Drugs Changing the Landscape of Precision Oncology?Regional Overview of Executive Summary Synthetic Lethality Drug Market Market by Size and Share CAGR Value The global Synthetic Lethality Drug market size was valued at USD 1.93 billion in 2025 and is expected to reach USD 8.07 billion by 2033, at a CAGR of 19.60% during the forecast period This Synthetic Lethality Drug Market report helps you to...0 Σχόλια 0 Μοιράστηκε 565 Views 0 Προεπισκόπηση
-
Investment Trends in the Anti-cancer Drugs MarketThe increasing focus on biologics and biosimilars is transforming the anti-cancer drugs industry. These advanced therapies offer new treatment options for patients with complex cancers. Their rising adoption is expected to drive long-term market expansion. The Anti-cancer Drugs Market is anticipated to expand at a CAGR of 9.2% from 2026 to 2034, reflecting steady innovation and increasing...0 Σχόλια 0 Μοιράστηκε 994 Views 0 Προεπισκόπηση
-
Is Nanomedicine Revolutionizing the Future of Healthcare?Executive Summary Nanomedicine Market Size and Share Forecast CAGR Value The global nanomedicine market size was valued at USD 479.30 million in 2024 and is expected to reach USD 1,247.40 million by 2032, at a CAGR of 12.70% during the forecast period The comprehensive market information and data of the Nanomedicine report will surely grow...0 Σχόλια 0 Μοιράστηκε 442 Views 0 Προεπισκόπηση
-
Is the Global Colorectal Cancer Treatment Market Advancing with Breakthrough Oncology Therapies?Executive Summary Colorectal Cancer Treatment Market Size and Share Across Top Segments CAGR Value Data Bridge Market Research analyses a growth rate in the colorectal cancer treatment market in the forecast period 2023-2030. The expected CAGR of colorectal cancer treatment market is tend to be around 4% in the mentioned forecast period. Market drivers and market restraints...0 Σχόλια 0 Μοιράστηκε 784 Views 0 Προεπισκόπηση
-
Is the Global Inhaled Antibiotics Market Advancing Respiratory Infection Management?Detailed Analysis of Executive Summary Inhaled Antibiotics Market Size and Share Data Bridge Market Research analyses that the Inhaled Antibiotics market which was USD 1,274.12 million in 2022, would rocket up to USD 2,046.13 million by 2030, and is expected to undergo a CAGR of 6.1% during the forecast period The Inhaled Antibiotics report makes available the current and forthcoming...0 Σχόλια 0 Μοιράστηκε 1χλμ. Views 0 Προεπισκόπηση
Αναζήτηση αποτελεσμάτων
Προωθημένο
Προωθημένο
English
Arabic
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)